Acadia Pharmaceuticals
ACAD
ACAD
246 hedge funds and large institutions have $3.44B invested in Acadia Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 69 increasing their positions, 94 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 236 → 246 (+10)
2.02% more ownership
Funds ownership: 90.16% → 92.19% (+2%)
27% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 94
Holders
246
Holding in Top 10
3
Calls
$87.4M
Puts
$16.3M
Top Buyers
| 1 | +$71.4M | |
| 2 | +$37M | |
| 3 | +$17.5M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$16.7M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$16.5M |
Top Sellers
| 1 | -$47.5M | |
| 2 | -$24.4M | |
| 3 | -$21.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$12.7M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$10.4M |